JCRB1170 SKNO-1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1170 | Cell Name | SKNO-1 |
---|---|---|---|
Profile | a GM-CSF dependent cell line with an t8,21 chromosome translocation estabulished from a patient attacked by acute myeloid leukemia(AML) | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 22 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | acute myeloblastic leukaemia (AML) | Metastasis | No |
Tissue Metastasized | Genetics | t(8;21), monosomy17, p53 mutation. | |
Life Span | infinite | Crisis PDL | |
Morphology | myeloblast | Character | MPO+, CAE+, NBE-. |
Classify | tumor | Established by | |
Registered by | Kawaguchi, R. | Regulation for Distribution | |
Comment | Year | 2006 | |
Medium | RPMI 1640 with 10% Fetal Bovine Serum and 10 ng/ml rhGM-CFS(recombinant human granurocyte-macrophage colonystimulating factor) | Methods for Passages | |
Cell Number on Passage | Race | Japanese | |
CO2 Conc. | 5% | Tissue Sampling | bone marrow |
Tissue Type | myeloblast |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:9029185 | Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with A t(8;21) chromosome translocation. Miyoshi H,Ohki M,Nakagawa T,Honma Y Leuk Res. 1997 Jan;21(1):45-50 |
Pubmed id:7772516 | Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Matozaki S,Nakagawa T,Kawaguchi R,Aozaki R,Tsutsumi M,Murayama T,Koizumi T,Nishimura R,Isobe T,Chihara K Br J Haematol. 1995 Apr;89(4):805-11 |
Pubmed id:7972130 | Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Sakakura C,Yamaguchi-Iwai Y,Satake M,Bae SC,Takahashi A,Ogawa E,Hagiwara A,Takahashi T,Murakami A,Makino K Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11723-7 |
Pubmed id:8136267 | Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome. Nakagawa T,Matozaki S,Murayama T,Nishimura R,Tsutsumi M,Kawaguchi R,Yokoyama Y,Hikiji K,Isobe T,Chihara K Br J Haematol. 1993 Nov;85(3):469-76 |
Pubmed id:2096594 | A case of epidural granulocytic sarcoma preceding acute leukemia. Watanabe M,Sashikata T,Kizaki T,Fujiwara T,Ugai K,Nakagawa T Acta Pathol Jpn. 1990 Dec;40(12):922-6 |
Images |
---|
LOT Information
Cell No. | JCRB1170 | Cell Name | |
---|---|---|---|
LOT No. | 06112012 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS, GIBCO Cat. # 10099) and 10 ng/mL recombinant human GM-CSF | Temperature | 37 C |
Cell Density at Seeding | 2.9 - 4.3 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). |
Doubling Time | approx. 38 hrs. | Cell Number in Vial (cells/1ml) | 2.8 x 10^6 |
Viability at cell freezing (%) | 90.8 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1170 | Cell Name | SKNO-1 |
---|---|---|---|
LOT No. | 08192006 | Lot Specification | distribution |
Medium | RPMI1640 with 10% heat inactivated fetal bovine serum and 10ng/ml rhGM-CFS(recombinant human granurocyte-macrophage colonystimulating facter) | Temperature | 37 C |
Cell Density at Seeding | NT | Methods for Passages | subculture by dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | NT |
Viability at cell freezing (%) | NT | Antibiotics Used | |
Passage Number | P4* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | G6PD(typeB),NP,LDH were examined.Human,not HeLa |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:10,13 D13S317:8,11 D7S820:10,12 D16S539:10,11 VWA:14,17 TH01:7 AM:X TPOX:8,9 CSF1PO:12,13 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | NT | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1170 | Cell Name | SKNO-1 |
---|---|---|---|
LOT No. | 02032016 | Lot Specification | distribution |
Medium | RPMI-1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) and 10 ng/ml recombinant human GM-CSF | Temperature | 37 C |
Cell Density at Seeding | 4.8 - 7.5 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). |
Doubling Time | 52 - 57 hrs | Cell Number in Vial (cells/1ml) | 5.6 x 10^6 |
Viability at cell freezing (%) | 87.1 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 87.1 | Additional information |